DEAL NOTE: Crowell & Moring Advises Marshall Wace on Series D Investment in InBrace
Firm News | 1 min read | 09.15.21
San Francisco—September 15, 2021: On September 8, 2021, InBrace, a dental company focused on teeth straightening, announced the closing of an oversubscribed $102 million Series D financing. Crowell & Moring represented co-lead investor Marshall Wace, a global alternative investment manager, in the transaction. InBrace intends to use proceeds of the Series D financing to accelerate growth by expanding its sales force, launching new marketing initiatives, and driving further support and integration with new and existing orthodontic providers across the country.
The financing was co-led by Farallon Capital Management. Additional new investors included funds and accounts managed by BlackRock, Endeavour Vision, MVM Partners, RTW Investments, LP, and Soleus Capital Management, L.P. as well as funds affiliated with existing investors Vivo Capital, Novo Ventures, and venBio. The deal was led by Jon O’Connell with contributions from John Fuson, Anne Li, Steve Ryan, and Justin Lurie.
Insights
Firm News | 2 min read | 07.03.25
Crowell & Moring U.K. LLP Appointed to U.K. Charity Commission Interim Managers List
Crowell & Moring announced today that four team members of its London office have been approved by The U.K. Charity Commission as practitioners considered for future Interim Manager appointments.
Firm News | 1 min read | 07.02.25
Derick D. Dailey Elected to the Board of Trustees of Legal Services of New Jersey
Firm News | 1 min read | 07.01.25
Four Crowell Attorneys Named World Trademark Review 2025 Global Leaders
Firm News | 5 min read | 07.01.25
Highly Regarded Patent Team to Join Crowell & Moring in London